{{Rsnum
|rsid=61888800
|Gene=BDNF
|Chromosome=11
|position=27700731
|Orientation=plus
|GMAF=0.1364
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene_s=BDNF
}}{{PharmGKB
|RSID=rs61888800
|Name_s=
|Gene_s=BDNF
|Feature=
|Evidence=PubMed ID:19414708
|Annotation=This variant in the 5' untranslated region of BDNF was associated with antidepressant response after adjusting for age, sex, medication, and baseline score on the 21-item Hamilton Depression Rating Scale in a study of 264 controls and 272 Mexican Americans with major depressive disorder.
|Drugs=
|Drug Classes=ANTIDEPRESSANTS
|Diseases=Depression; Depressive Disorder, Major
|Curation Level=Curated
|PharmGKB Accession ID=PA164857048
}}

{{PMID Auto
|PMID=19721723
|Title=Brain-derived neurotrophic factor: role in depression and suicide.
|OA=1
}}

{{PMID Auto
|PMID=21172166
|Title=Pharmacogenetics of antidepressant response.
|OA=1
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs61888800
|overall_frequency_n=7
|overall_frequency_d=68
|overall_frequency=0.102941
|n_genomes=6
|n_genomes_annotated=0
|n_haplomes=7
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=2
|webscore=N
|n_web_uneval=10
}}

{{PMID Auto
|PMID=23532066
|Title=BDNF polymorphism rs11030101 is associated with the efficacy of electroconvulsive therapy in treatment-resistant depression
}}

{{PMID Auto
|PMID=23250003
|Title=No support for a role for BDNF gene polymorphisms rs11030101 and rs61888800 in major depressive disorder or antidepressant response in patients of Finnish origin.
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}